{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'Hutchinson AF, Ghimire AK, Thompson MA et al. A community-based, time-matched,', 'case-control study of respiratory viruses and exacerbations of COPD. Respir Med. 2007;', '101: 2472-81.', 'Jones P, Miravitlles M, van der Molen T et al. Beyond FEV1 in COPD: a review of', 'patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis.', '2012; 7: 697-709.', 'Ko FW, Ip M, Chan PK et al. A 1-year prospective study of the infectious etiology in', 'patients hospitalized with acute exacerbations of COPD. Chest. 2007; 131: 44-52.', 'Ko FWS, Hui DSC, Lai CKW et al. Worldwide burden of COPD in high- and low-', 'income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008;12(7):713-', '717.', 'Leidy NK, Wilcox TK, Jones PW et al. Standardizing measurement of chronic', 'obstructive pulmonary disease exacerbations. Reliability and validity of a patient-', 'reported diary. Am J Respir Crit Care Med. 2011; 183: 323-9.', 'Lim Sam, Lam Chi-Leung David et al. Impact of chronic obstructive pulmonary disease', '(COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pacific', 'Family Medicine. 2015; 14:4', 'Mathers CD and Loncar D. Projections of global mortality and burden of disease from', '2002 to 2030. PLoS Med. 2006; 3: e442.', 'Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria', 'important? Eur Respir J Suppl. 2002; 36: 9s-19s.', 'Mohan A, Chandra S, Agarwal D et al. Prevalence of viral infection detected by PCR and', 'RT-PCR in patients with acute exacerbation of COPD: A systematic review. Respirology.', '2010;15(5):536.42.', 'Mons\u00f3 E, Ruiz J, Rosell A et al. Bacterial infection in chronic obstructive pulmonary', 'disease. A study of stable and exacerbated outpatients using the protected specimen', 'brush. Am J Respir Crit Care Med. 1995; 152: 1316-20.', 'Papi A, Bellettato CM, Braccioni F et al. Infections and airway inflammation in chronic', 'obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;', '173: 1114-21.', 'Perotin JM, Dury S, Renois F et al. Detection of multiple viral and bacterial infections in', 'acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J', 'Med Virol. 2013; 85: 866-73.', 'Singh Richa, Mackay AJ et al. Inflammatory thresholds and the species-specific effects', 'of colonising bacteria in stable chronic obstructive pulmonary disease. Respiratory', 'Research. 2014; 15: 114.', '19-OCT-2018', '76', '75661ebdab2e949f7a1f1bc2071b9dec72acecc']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'Sapey E, Stockley RA. COPD exacerbations 2: aetiology. Thorax. 2006; 61: 250-8.', 'Tan WC, Seale P, Ip M et al. Trends in COPD mortality and hospitalizations in countries', 'and regions of Asia-Pacific. Respirology. 2009; 14: 90-7.', 'Wedzicha JA and Seemungal TA. COPD exacerbations: defining their cause and', 'prevention. Lancet. 2007; 370: 786-96.', 'World Health Organization (WHO). Priority environment and health risks. 2013.', 'Available from: http://www.who.int/heli/risks/indoorair/indoorair/en/#. Accessed: 27 July', '2016.', 'World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD) Fact', 'Sheet. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/', 'Accessed: 20 October 2017.', 'Wilkinson TM, Hurst JR, Perera WR et al. Effect of interactions between lower airway', 'bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129: 317-24.', 'Ye F, He LX, Cai BQ et al. Spectrum and antimicrobial resistance of common pathogenic', 'bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary', 'disease in mainland of China. Chin Med J (Engl). 2013; 126: 2207-14.', '19-OCT-2018', '77', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']\n\n###\n\n", "completion": "END"}